APYX
Apyx Medical Corp
$
3.200
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.200
Open
3.030
VWAP
3.03
Vol
124.92K
Mkt Cap
121.02M
Low
2.870
Amount
378.64K
EV/EBITDA(TTM)
--
Total Shares
34.64M
EV
119.90M
EV/OCF(TTM)
--
P/S(TTM)
2.51
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
10.14M
+7.57%
-0.117
+16.67%
17.17M
+20.74%
-0.057
-52.78%
12.00M
+4.46%
-0.100
-28.57%
Estimates Revision
The market is revising Downward the revenue expectations for Apyx Medical Corporation (APYX) for FY2025, with the revenue forecasts being adjusted by -0.03% over the past three months. During the same period, the stock price has changed by 72.97%.
Revenue Estimates for FY2025
Revise Downward
-0.03%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+11.36%
In Past 3 Month
Stock Price
Go Up
+72.97%
In Past 3 Month
4 Analyst Rating
Wall Street analysts forecast APYX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for APYX is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 3.200
Low
4.00
Averages
4.00
High
4.00
Current: 3.200
Low
4.00
Averages
4.00
High
4.00
The End
No Data
Valuation Metrics
The current forward P/E ratio for Apyx Medical Corp (APYX.O) is -7.82, compared to its 5-year average forward P/E of -10.29. For a more detailed relative valuation and DCF analysis to assess Apyx Medical Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-10.29
Current PE
-7.82
Overvalued PE
-2.46
Undervalued PE
-18.12
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-15.24
Current EV/EBITDA
-15.45
Overvalued EV/EBITDA
-4.53
Undervalued EV/EBITDA
-25.96
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
3.54
Current PS
3.03
Overvalued PS
6.35
Undervalued PS
0.73
Financials
Annual
Quarterly
FY2025Q2
YoY :
-6.39%
11.37M
Total Revenue
FY2025Q2
YoY :
-53.60%
-2.57M
Operating Profit
FY2025Q2
YoY :
-43.24%
-3.74M
Net Income after Tax
FY2025Q2
YoY :
-52.63%
-0.09
EPS - Diluted
FY2025Q2
YoY :
-67.56%
-1.50M
Free Cash Flow
FY2025Q2
YoY :
+0.97%
62.28
Gross Profit Margin - %
FY2025Q2
YoY :
+8.12%
-21.56
FCF Margin - %
FY2025Q2
YoY :
-39.37%
-32.87
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
1
150.0K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
APYX News & Events
Events Timeline
2025-10-13 (ET)
2025-10-13
08:03:51
Apyx Medical files FDA 510(k) application for AYON label expansion in the U.S.
2025-07-28 (ET)
2025-07-28
08:08:34
Apyx Medical announces launch of Renuvion in China
2025-05-13 (ET)
2025-05-13
08:14:50
Apyx Medical receives FDA clearance for AYON Body Contouring System
Sign Up For More Events
Sign Up For More Events
News
9.0
10-13NASDAQ.COMApyx Medical Pursues FDA Approval for Broader Application of AYON Body Contouring System
1.0
07-30NewsfilterApyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
5.0
05-30NewsfilterRenuvion® Brings Real Transformations to the Runway at Miami Swim Week
Sign Up For More News
People Also Watch
FAQ
What is Apyx Medical Corp (APYX) stock price today?
The current price of APYX is 3.2 USD — it has increased 5.61 % in the last trading day.
What is Apyx Medical Corp (APYX)'s business?
What is the price predicton of APYX Stock?
What is Apyx Medical Corp (APYX)'s revenue for the last quarter?
What is Apyx Medical Corp (APYX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Apyx Medical Corp (APYX)'s fundamentals?
How many employees does Apyx Medical Corp (APYX). have?